Hosted by Maureen McGrath, RN
Promescent CEO Jeff Abraham joined Nurse Maureen McGrath on her health show for an honest, science-backed conversation on premature ejaculation — the stigma, the orgasm gap, the clinical trial that changed everything, and why better intimacy is about far more than just lasting longer.
Premature ejaculation affects an estimated 30% of men at some point in their lives, yet it remains one of the most stigmatized and least-discussed sexual health concerns. On Nurse Maureen's Health Show, registered nurse and sexual health educator Maureen McGrath sat down with Jeff Abraham, CEO of Promescent, for an open, science-backed conversation that cuts through the silence - and offers real answers.
Most people have a narrow definition of PE - finishing too fast. But Jeff Abraham pushes that definition further, centering the partner's experience in the conversation.
"Because if someone lasts two minutes and their partner takes a lot longer to climax, then I would really argue that that would also classify as premature ejaculation."
This framing matters. PE isn't just a solo performance issue - it's a couples issue. When one partner consistently reaches climax long before the other, the intimacy gap widens. The orgasm gap is well-documented in clinical research: on average, men reach orgasm in about 5 minutes, while women typically require 14 to 18 minutes of stimulation. That gap is where PE does its real damage.
Premature ejaculation affects approximately 1 in 3 men globally and is clinically recognized as the most common male sexual dysfunction - more prevalent than erectile dysfunction, according to data published in the Journal of Sexual Medicine.
Part of why PE goes unaddressed is cultural. Comedians joke about it. Men don't talk about it with their doctors, their partners, or even their friends. The result is isolation - and often, a worsening condition.
"And I tell people, 'You're not alone,' because so many people, because people are afraid to talk about it, and they make it, like, almost stigmatized."
Abraham makes the point that the stigma itself becomes a barrier to treatment - and that barrier is costly. When PE goes unaddressed, the psychological weight compounds. Men begin to anticipate failure before intimacy begins, which creates a feedback loop of anxiety that makes the condition worse over time.
One of the most important - and least-known - insights Jeff Abraham shares in this episode is the physiological connection between untreated PE and erectile dysfunction.
"But eventually, if you have chronic PE, you'll develop an inability to get an erection because your body knows that it leads to an unsatisfactory conclusion."
This is not just anecdotal. The anticipatory anxiety that builds around PE can suppress the physiological arousal response over time. Addressing PE early isn't just about better sex today - it's about protecting sexual function long-term. The American Urological Association recognizes PE as a treatable condition with multiple evidence-based interventions.
Promescent's approach to PE reflects the complexity of the condition. There is no single solution because PE does not have a single cause - it can be physiological, psychological, or a combination of both.
"So there, depending upon the severity of the PE, there's a number of tools in that toolbox you can use."
For men whose PE has a strong psychological component, Promescent's delay spray can serve double duty - not only extending time to climax through its targeted lidocaine formula, but also breaking the anticipatory anxiety cycle by giving men a reliable tool they can count on. When the fear of finishing early is removed, confidence returns. And with confidence, performance often follows.
"If your premature ejaculation is strictly a psychological issue, we can be helpful in the fact that it can help you last longer."
For couples navigating this together, Promescent Delay Spray was specifically formulated with an anti-transfer technology so the lidocaine absorbs into the tissue and does not transfer to a partner - a common concern with other delay products. Additional options like couples intimacy products and education on PE treatment approaches round out a full toolkit.
What distinguishes Promescent from the crowded field of delay products is clinical validation. The formula underwent an IRB-certified clinical trial - one of the few over-the-counter sexual wellness products to do so. The results demonstrated statistically significant improvements in time to climax and partner satisfaction.
In an IRB-certified clinical trial, Promescent Delay Spray demonstrated a 64% improvement in time to ejaculation and significantly higher partner satisfaction scores compared to placebo - making it one of the most rigorously tested OTC delay products on the market.
Jeff Abraham credits much of the product's refinement to direct customer feedback - a practice he describes as central to Promescent's development philosophy.
"The best way, like you say, to learn about your product is talk to your customers."
That feedback loop is how the anti-transfer formula was perfected and how dosing guidance became as precise as it is. Unlike competitors, Promescent provides specific application instructions so users can dial in the right amount for their situation - starting low and adjusting - rather than guessing.
Perhaps the most important message from this episode is the simplest: PE is common, treatable, and nothing to be ashamed of. The stigma around it is a cultural artifact, not a clinical reality. Millions of men experience it. Effective tools exist. And the conversation - the one Maureen McGrath and Jeff Abraham are having openly - is how that stigma starts to break down.
If you or your partner are navigating PE, the starting point is the same one Jeff Abraham offers to every customer he speaks with: you are not alone, and there is a toolbox waiting for you.
Listen to the full episode on Apple Podcasts.
Your Cart Is Empty
